Sanofi-Aventis U.S. LLC et al v. Mylan Laboratories Limited
| Sanofi Mature IP and Sanofi-Aventis U.S. LLC |
| Mylan Laboratories Limited |
| 1:2020cv00761 |
| June 5, 2020 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 31, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorneys William E. Solander and Daniel J. Minion for Sanofi Mature IP and Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00646-RGA, 1:20-cv-00761-RGA, 1:20-cv-00803-RGA, 1:20-cv-00804-RGA(kmd) |
| Filing 17 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,716,777 . (Blumenfeld, Jack) |
| Filing 16 First AMENDED COMPLAINT against Mylan Laboratories Limited- filed by Sanofi-Aventis U.S. LLC, Sanofi Mature IP. (Attachments: #1 Exhibits A-C)(Blumenfeld, Jack) |
Filing 15
Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 8/7/2020, at 10:00 AM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 7/6/2020. (nms)
|
| Filing 14 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan Inc. for Mylan Laboratories Limited filed by Mylan Laboratories Limited. (Moore, David) |
| Filing 13 ANSWER to #1 Complaint, Separate Defenses, and COUNTERCLAIMS against Sanofi Mature IP, Sanofi-Aventis U.S. LLC by Mylan Laboratories Limited.(Moore, David) Modified on 7/6/2020 (nms). |
| Filing 12 Letter to The Honorable Richard G. Andrews, from David E. Moore, Esq., regarding request for an early Rule 16 conference. (Moore, David) Modified on 7/2/2020 (nms). |
| Pro Hac Vice Attorney Michael S. Scerbo for Sanofi Mature IP and Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00646-RGA, 1:20-cv-00761-RGA, 1:20-cv-00803-RGA, 1:20-cv-00804-RGA(mal) |
| Filing 11 Letter to The Honorable Richard G. Andrews from Jack B. Blumenfeld regarding request for an early Rule 16 conference. (Blumenfeld, Jack) |
|
SO ORDERED, re (10 in 20-cv-761-RGA; 11 in 20-cv-46-RGA; 9 in 20-cv-803-RGA; 24 in 20-cv-804-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jiang Lin, filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. Signed by Judge Richard G. Andrews on 6/25/2020. Associated Cases: 1:20-cv-00646-RGA, 1:20-cv-00761-RGA, 1:20-cv-00803-RGA, 1:20-cv-00804-RGA(nms)
|
| Pro Hac Vice Attorney Whitney L. Meier for Sanofi Mature IP, for Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Jiang Lin - filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Fahnestock, Derek) |
| Filing 9 MOTION for Pro Hac Vice Appearance of Attorney William E. Solander, Daniel J. Minion, Whitney L. Meier and Michael S. Scerbo - filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Fahnestock, Derek) |
|
SO ORDERED, re (9 in 20-cv-761-RGA; 8 in 20-cv-803-RGA; 10 in 20-cv-646-RGA; 23 in 20-cv-804-RGA) MOTION for Pro Hac Vice Appearance of Attorney William E. Solander, Daniel J. Minion, Whitney L. Meier and Michael S. Scerbo, filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. Signed by Judge Richard G. Andrews on 6/24/2020. Associated Cases: 1:20-cv-00646-RGA, 1:20-cv-00761-RGA, 1:20-cv-00803-RGA, 1:20-cv-00804-RGA(nms)
|
| Pro Hac Vice Attorney Kristina M. Hanson for Mylan Laboratories Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Pro Hac Vice Attorney Edward Powell, III for Mylan Laboratories Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Pro Hac Vice Attorney Matthew R. Reed for Mylan Laboratories Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Pro Hac Vice Attorney Wendy L. Devine for Mylan Laboratories Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Filing 8 MOTION for Pro Hac Vice Appearance of Attorney Wendy Lynn Devine, Kristina M. Hanson, Matthew R. Reed, and G. Edward Powell, III of Wilson Sonsini Goodrich and Rosati - filed by Mylan Laboratories Limited. (Palapura, Bindu) |
|
SO ORDERED, re #8 MOTION for Pro Hac Vice Appearance of Attorney Wendy Lynn Devine, Kristina M. Hanson, Matthew R. Reed, and G. Edward Powell, III of Wilson Sonsini Goodrich and Rosati, filed by Mylan Laboratories Limited. Signed by Judge Richard G. Andrews on 6/19/2020. (nms)
|
| Filing 7 AFFIDAVIT of Service for Summons, Complaint and Related Papers served on Mylan Laboratories Limited on June 11, 2020, filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Blumenfeld, Jack) |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (mal) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Sanofi Mature IP, and Sanofi-Aventis U.S. LLC filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (mal) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,583,110 B2. (mal) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 29, 2020. Date of Expiration of Patent: October 27, 2030. Thirty Month Stay Deadline: Not Applicable. (mal) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Mylan Laboratories Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-2976604.) - filed by Sanofi-Aventis U.S. LLC, Sanofi Mature IP. (Attachments: #1 Exhibit A-B, #2 Civil Cover Sheet)(mal) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
